nocodazole and fosbretabulin

nocodazole has been researched along with fosbretabulin in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (14.29)29.6817
2010's12 (85.71)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burger, AM; Camacho Gomez, JA; Düssmann, H; Günther, EG; Hirano, T; Ishii, Y; Prehn, JH; Prinz, H; Schmidt, P; Stoiber, T; Umezawa, K; Unger, E1
Bhadra, MP; Bharathi, EV; Dastagiri, D; Kamal, A; Pushpavalli, SN; Ramaiah, MJ; Reddy, JS; Reddy, MK; Reddy, TL; Shaik, TB; Viswanath, A1
Addlagatta, A; Kamal, A; Kishor, C; Lakshma Nayak, V; Mallareddy, A; Ramakrishna, S; Sankara Rao, N; Shaik, TB; Shetti, RV; Suresh, P; Tamboli, JR1
Addlagatta, A; Ghosh, S; Janaki Ramaiah, M; Kamal, A; Kishor, C; Mallareddy, A; Murty, JN; Pal-Bhadra, M; Pushpavalli, SN; Rao, NS; Suresh, P1
Antus, S; Bai, R; Basso, G; Bényei, AC; Hamel, E; Porcù, E; Schmidhammer, H; Sipos, A; Stempfer, V; Udvardy, A; Viola, G1
Madala, HR; Mikelis, C; Punganuru, SR; Samala, R; Srivenugopal, KS; Venugopal, SN1
Bai, R; Betancourt, T; Dasari, R; Frail, SK; Frolova, LV; Hamel, E; Hill, RM; Kornienko, A; LaBarbera, DV; Medellin, DC; Ontiveros, SJ; Pelly, SC; Rogelj, S; Scott, R; Shuster, CB; van Otterlo, WA; Zhou, Q1
Meegan, MJ; Nathwani, S; O'Boyle, NM; Twamley, B; Zisterer, DM1
Alvala, M; Amaroju, S; Bhattacharjee, D; Chitti, S; Jain, N; Narva, S; Rao, BB; Sekhar, KVGC1
Babu, KS; Jain, N; Misra, S; Poornima, B; Shankaraiah, G; Siva, B; Venkanna, A; Yadav, DK1
Bantu, R; Banu, S; Bollu, R; Jain, N; Kasaboina, S; Nagarapu, L; Polepalli, S1
Diaz, P; Gussio, R; Haas, B; Hamel, E; Horne, E; Hothi, P; Petrov, RR; Stella, N; Uhlenbruck, B; Wagenbach, M; Wordeman, L; Xu, C1
Dank, C; Dzubak, P; Fuerst, R; Gurska, S; Hajduch, M; Kauderer, M; Mokshyna, O; Nowikow, C; Polishchuk, P; Rehulka, J; Rinner, U; Schmid, W; Zupkó, I1
Burnett, JC; Day, BW; Gussio, R; Hamel, E; Hermone, AR; McGrath, C; Nguyen, TL; Wipf, P; Zaharevitz, DW1

Other Studies

14 other study(ies) available for nocodazole and fosbretabulin

ArticleYear
Novel benzylidene-9(10H)-anthracenones as highly active antimicrotubule agents. Synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
    Journal of medicinal chemistry, 2003, Jul-17, Volume: 46, Issue:15

    Topics: Anthracenes; Antineoplastic Agents; Apoptosis; Biopolymers; Blotting, Western; Cell Cycle; Cell Survival; Drug Screening Assays, Antitumor; Humans; K562 Cells; Microscopy, Electron; Structure-Activity Relationship; Tubulin

2003
Synthesis and biological evaluation of 3,5-diaryl isoxazoline/isoxazole linked 2,3-dihydroquinazolinone hybrids as anticancer agents.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:2

    Topics: Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Isoxazoles; Molecular Structure; Quinazolinones; Stereoisomerism

2011
Synthesis of chalcone-amidobenzothiazole conjugates as antimitotic and apoptotic inducing agents.
    Bioorganic & medicinal chemistry, 2012, Jun-01, Volume: 20, Issue:11

    Topics: Antimitotic Agents; Antineoplastic Agents; Apoptosis; Benzothiazoles; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Chalcone; Drug Screening Assays, Antitumor; Fluorescent Antibody Technique; Humans; Inhibitory Concentration 50; Microtubules; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Tubulin

2012
Synthesis and biological evaluation of combretastatin-amidobenzothiazole conjugates as potential anticancer agents.
    European journal of medicinal chemistry, 2012, Volume: 56

    Topics: Antimitotic Agents; Benzothiazoles; Bibenzyls; Cell Cycle; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; MCF-7 Cells; Models, Molecular; Molecular Dynamics Simulation; Molecular Structure; Polymerization; Structure-Activity Relationship; Tubulin; Tumor Cells, Cultured

2012
Novel 9'-substituted-noscapines: synthesis with Suzuki cross-coupling, structure elucidation and biological evaluation.
    European journal of medicinal chemistry, 2014, Sep-12, Volume: 84

    Topics: Apoptosis; Apoptosis Regulatory Proteins; Dose-Response Relationship, Drug; HeLa Cells; Humans; Jurkat Cells; Molecular Docking Simulation; Noscapine; Structure-Activity Relationship

2014
Design and synthesis of a C7-aryl piperlongumine derivative with potent antimicrotubule and mutant p53-reactivating properties.
    European journal of medicinal chemistry, 2016, Jan-01, Volume: 107

    Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Chemistry Techniques, Synthetic; Dioxolanes; Drug Design; Female; Genes, Tumor Suppressor; Glutathione; Humans; Microtubules; Mutation; Reactive Oxygen Species; Stilbenes; Tumor Suppressor Protein p53

2016
Novel Microtubule-Targeting 7-Deazahypoxanthines Derived from Marine Alkaloid Rigidins with Potent in Vitro and in Vivo Anticancer Activities.
    Journal of medicinal chemistry, 2016, Jan-14, Volume: 59, Issue:1

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Colchicine; Colonic Neoplasms; Drug Design; Drug Screening Assays, Antitumor; Female; Humans; Marine Toxins; Mice; Mice, Nude; Models, Molecular; Molecular Docking Simulation; Structure-Activity Relationship; Tubulin; Tubulin Modulators; Xanthines

2016
Piperlongumine (piplartine) and analogues: Antiproliferative microtubule-destabilising agents.
    European journal of medicinal chemistry, 2017, Jan-05, Volume: 125

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Survival; Dioxolanes; Female; Humans; MCF-7 Cells; Microtubules; Models, Molecular; Piperidones; Reactive Oxygen Species; Structure-Activity Relationship; Tubulin; Tubulin Modulators

2017
Design and synthesis of 4-morpholino-6-(1,2,3,6-tetrahydropyridin-4-yl)-N-(3,4,5-trimethoxyphenyl)-1,3,5-triazin-2-amine analogues as tubulin polymerization inhibitors.
    Bioorganic & medicinal chemistry letters, 2017, 08-15, Volume: 27, Issue:16

    Topics: Amines; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Molecular Docking Simulation; Molecular Structure; Polymerization; Structure-Activity Relationship; Tubulin

2017
Novel Gomisin B analogues as potential cytotoxic agents: Design, synthesis, biological evaluation and docking studies.
    European journal of medicinal chemistry, 2017, Oct-20, Volume: 139

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cyclooctanes; Cytotoxins; Dioxoles; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Lignans; Molecular Docking Simulation; Molecular Structure; Polycyclic Compounds; Schisandra; Structure-Activity Relationship

2017
Potential anti-proliferative agents from 1,4-benzoxazinone-quinazolin-4(3H)-one templates.
    Bioorganic & medicinal chemistry letters, 2017, 12-15, Volume: 27, Issue:24

    Topics: Antineoplastic Agents; Apoptosis; Benzoxazines; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Screening Assays, Antitumor; HeLa Cells; Humans; Quinazolinones; Structure-Activity Relationship

2017
Modified carbazoles destabilize microtubules and kill glioblastoma multiform cells.
    European journal of medicinal chemistry, 2018, Nov-05, Volume: 159

    Topics: Antineoplastic Agents; Carbazoles; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Glioblastoma; Humans; Microtubules; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship

2018
Synthesis and biological evaluation of cis-restrained carbocyclic combretastatin A-4 analogs: Influence of the ring size and saturation on cytotoxic properties.
    Bioorganic & medicinal chemistry, 2019, 10-01, Volume: 27, Issue:19

    Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Screening Assays, Antitumor; G2 Phase Cell Cycle Checkpoints; Humans; Molecular Docking Simulation; Molecular Structure; Protein Binding; Stilbenes; Tubulin; Tubulin Modulators

2019
A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach.
    Journal of medicinal chemistry, 2005, Sep-22, Volume: 48, Issue:19

    Topics: 2-Methoxyestradiol; 4-Butyrolactone; Aminophenols; Binding Sites; Chalcone; Colchicine; Cyclopropanes; Estradiol; Indans; Lignans; Models, Molecular; Molecular Structure; Nocodazole; Podophyllotoxin; Protein Binding; Stilbenes; Structure-Activity Relationship; Sulfonamides; Thiazoles; Tubulin; Tubulin Modulators

2005